A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline
ConclusionsIn this real-world setting, eravacycline demonstrated a similar high level of clinical efficacy as seen in clinical trials, 94%, in a variety of infections, including against multidrug-resistant bacteria, and was well tolerated.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Antibiotic Therapy | Clinical Trials | Diabetes | Endocrinology | Infectious Diseases | Multidrug Resistance | Peritonitis | Pneumonia | Study